HARES BANUWAL OD
Prescription History 1285293100
Optometrist in Oxon Hill, MD
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for HARES BANUWAL OD, an active Optometrist specialist practicing in Oxon Hill, MD. Our medical registry currently tracks 9 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 349 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 169 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MD PrescribersVs. MD Avg |
|---|---|---|---|
| Latanoprost | 169 | $7.68▼ below MD avg | ≈ Typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2024, this provider wrote 169 Medicare prescriptions for Latanoprost, about 1.2 times the volume of the typical Maryland prescriber of this medication (136.4). Medicare paid an average of $7.68 per fill, versus $14.32 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 347.3 30-Day Fills standardized to 30-day supplies 9,995 Days of Medication total across all patients in 2024 | |||
| RestasisCyclosporine | 34 | $1,237.79 | ≈ Typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). In 2024, this provider wrote 34 Medicare prescriptions for Restasis, about the same volume as the typical Maryland prescriber of this medication (37.6). Medicare paid an average of $1,237.79 per fill, versus $1,183.80 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 66 30-Day Fills standardized to 30-day supplies 1,980 Days of Medication total across all patients in 2024 | |||
| XiidraLifitegrast | 32 | $1,387.15 | ≈ Typical |
About Xiidra: This medication is used to treat dry eye disease. Show more ▾ An LFA-1 (LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1) antagonist that is used in the treatment of DRY EYE SYNDROMES. In 2024, this provider wrote 32 Medicare prescriptions for Xiidra, about the same volume as the typical Maryland prescriber of this medication (34.5). Medicare paid an average of $1,387.15 per fill, versus $1,268.21 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 66 30-Day Fills standardized to 30-day supplies 1,981 Days of Medication total across all patients in 2024 | |||
| Azelastine Hcl | 28 | $42.42 | ≈ Typical |
About Azelastine Hcl: This medication is used to relieve nasal symptoms such as runny/itching/stuffy nose, sneezing, and post-nasal drip caused by allergies or other conditions. Show more ▾ Azelastine belongs to a class of drugs known as antihistamines. It works by blocking certain natural substances called histamines that are responsible for nasal symptoms. Azeptin is azelastine hydrochloride; structure; eye drop formulation effective in relieving symptoms of allergic conjunctivitis; do not confuse with 5-loxin which is an extract of Boswellia. In 2024, this provider wrote 28 Medicare prescriptions for Azelastine Hcl, about 84% of the volume of the typical Maryland prescriber of this medication (33.3). Medicare paid an average of $42.42 per fill, versus $31.50 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 54.3 30-Day Fills standardized to 30-day supplies 1,605 Days of Medication total across all patients in 2024 | |||
| Cyclosporine | 19 | $355.75▼ below MD avg | ▼ Less than typical |
About Cyclosporine: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). In 2024, this provider wrote 19 Medicare prescriptions for Cyclosporine, about half the volume of the typical Maryland prescriber of this medication (31.8). Medicare paid an average of $355.75 per fill, versus $399.86 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 41 30-Day Fills standardized to 30-day supplies 1,230 Days of Medication total across all patients in 2024 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 18 | $12.64▼ below MD avg | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2024, this provider wrote 18 Medicare prescriptions for Dorzolamide-Timolol, about 18% of the volume of the typical Maryland prescriber of this medication (97.8). Medicare paid an average of $12.64 per fill, versus $21.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 36.5 30-Day Fills standardized to 30-day supplies 1,096 Days of Medication total across all patients in 2024 | |||
| Brimonidine Tartrate | 17 | $15.50▼ below MD avg | ▼ Less than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 17 Medicare prescriptions for Brimonidine Tartrate, about a quarter of the volume of the typical Maryland prescriber of this medication (64.9). Medicare paid an average of $15.50 per fill, versus $48.99 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 47 30-Day Fills standardized to 30-day supplies 1,400 Days of Medication total across all patients in 2024 | |||
| Timolol Maleate | 17 | $4.34▼ below MD avg | ▼ Less than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2024, this provider wrote 17 Medicare prescriptions for Timolol Maleate, about a quarter of the volume of the typical Maryland prescriber of this medication (78.2). Medicare paid an average of $4.34 per fill, versus $22.76 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 41.2 30-Day Fills standardized to 30-day supplies 1,225 Days of Medication total across all patients in 2024 | |||
| ErythromycinErythromycin Base | 15 | $9.15▼ below MD avg | ▼ Less than typical |
About Erythromycin: This medication is used to treat certain eye infections (such as conjunctivitis). Show more ▾ It is also used to prevent certain eye infections in newborns. It belongs to a class of drugs known as macrolide antibiotics. Erythromycin works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. In 2024, this provider wrote 15 Medicare prescriptions for Erythromycin, about half the volume of the typical Maryland prescriber of this medication (32.8). Medicare paid an average of $9.15 per fill, versus $13.44 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 15 30-Day Fills standardized to 30-day supplies 154 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for HARES BANUWAL OD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Oxon Hill, MD practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MD prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
